Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
Abstract
Despite advances in early detection and therapies, cancer is still one of the most common causes of death worldwide. Since each tumor is unique, there is a need to implement personalized care and develop robust tools for monitoring treatment response to assess drug efficacy and prevent disease relapse.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 21, 2023
- Source ID
- 10.1186/s12943-022-01710-w
Entities
People
- Hani Goodarzi
- Josef Srovnal
- Laura J. van't Veer
- Marián Hajdúch
- Mark Jesus M. Magbanua
- Pavel Stejskal
Organizations
- European Regional Development Fund
- Ministry of Education
- Ministry of Health of the Czech Republic
- National Institutes of Health
- The Breast Cancer Research Foundation